Related Experiment Video
Updated: May 12, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis
Claudia Calcagno1, Sarayu Ramachandran, Antoine Millon
1Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1234, New York, NY 10029, USA, Department of Radiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.
Insights
Gadolinium-chelates (Gd) are revolutionizing atherosclerosis detection. These MRI contrast agents help identify high-risk individuals non-invasively, improving cardiovascular disease management.
Area of Science:
- Medical Imaging
- Cardiovascular Research
- Biochemistry
Background:
- Atherosclerosis is a leading cause of global mortality.
- Early detection of asymptomatic individuals is crucial for cardiovascular disease (CVD) prevention.
- Advances in molecular understanding of atherosclerosis enable novel diagnostic tools.
Purpose of the Study:
- To review gadolinium-chelate (Gd) based contrast agents for non-invasive magnetic resonance (MR) imaging of atherosclerosis.
- To discuss the application of Gd agents in characterizing atherosclerotic plaques.
- To highlight the potential of targeted contrast agents in understanding atherosclerotic processes.
Main Methods:
- Review of FDA-approved non-targeted Gd agents used in clinical practice.
- Description of non-specific and specific targeted Gd contrast agents for atherosclerosis.
- Comparison of Gd-based agents with other MRI contrast agents and imaging modalities.
Main Results:
- Gd-based contrast agents are valuable for in vivo characterization of atherosclerotic processes.
- Non-targeted agents are used for neovascularization, while targeted agents offer specific biological insights.
- Gd agents show promise for improved plaque characterization and early detection.
Conclusions:
- Gadolinium-chelates offer significant potential for non-invasive MR imaging of atherosclerosis.
- Targeted Gd agents can dissect specific molecular pathways in the atherosclerotic cascade.
- These agents represent a significant advancement in identifying high-risk individuals for cardiovascular disease.
Abstract:
Cardiovascular disease due to atherosclerosis is the number one killer in the Western world, and threatens to become the major cause of morbidity and mortality worldwide. It is therefore paramount to develop non-invasive methods for the detection of high-risk, asymptomatic individuals before the onset of clinical symptoms or events. In the recent past, great strides have been made in the understanding of the pathological mechanisms involved in the atherosclerotic cascade down to the molecular details. This has allowed the development of contrast agents that can aid in the in vivo characterization of these processes. Gadolinium chelates are among the contrast media most commonly used in MR imaging. Originally used for MR angiography for the detection and quantification of vascular stenosis, more recently they have been applied to improve characterization of atherosclerotic plaques. In this manuscript, we will briefly review gadolinium-chelates (Gd) based contrast agents for non-invasive MR imaging of atherosclerosis. We will first describe Gd-based non-targeted FDA approved agents, used routinely in clinical practice for the evaluation of neovascularization in other diseases. Secondly, we will describe non-specific and specific targeted contrast agents, which have great potential for dissecting specific biological processes in the atherosclerotic cascade. Lastly, we will briefly compare Gd-based agents to others commonly used in MRI and to other imaging modalities.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System V: CT
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies VII: Vascular Imaging
